Medtronic plc (MDT)
| Market Cap | 113.66B |
| Revenue (ttm) | 33.20B |
| Net Income (ttm) | 4.26B |
| Shares Out | 1.28B |
| EPS (ttm) | 3.27 |
| PE Ratio | 27.10 |
| Forward PE | 15.39 |
| Dividend | $2.80 (3.16%) |
| Ex-Dividend Date | Mar 28, 2025 |
| Volume | 7,458,589 |
| Open | 90.28 |
| Previous Close | 90.13 |
| Day's Range | 87.52 - 90.49 |
| 52-Week Range | 75.96 - 96.25 |
| Beta | 0.82 |
| Analysts | Hold |
| Price Target | 94.64 (+6.79%) |
| Earnings Date | May 22, 2025 |
About MDT
Medtronic plc develops, manufactures, and sells device-based medical therapies to healthcare systems, physicians, clinicians, and patients worldwide. The Cardiovascular Portfolio segment offers implantable cardiac pacemakers, cardioverter defibrillators, and cardiac resynchronization therapy devices; cardiac ablation products; insertable cardiac monitor systems; TYRX products; and remote monitoring and patient-centered software. It also provides aortic valves, surgical valve replacement and repair products, endovascular stent grafts and accesso... [Read more]
Financial Performance
In 2024, Medtronic's revenue was $32.36 billion, an increase of 3.64% compared to the previous year's $31.23 billion. Earnings were $3.68 billion, a decrease of -2.18%.
Financial StatementsAnalyst Forecast
According to 15 analysts, the average rating for MDT stock is "Hold." The 12-month stock price forecast is $94.64, which is an increase of 6.79% from the latest price.
News
Medtronic: Strength In Cardiac Ablation Solutions, Upgrade To Buy
Upgraded Medtronic to a ‘Buy' rating with a fair value of $105 per share, driven by strong growth in Cardiac Ablation Solutions and TAVR markets. Medtronic reported 4.1% organic revenue growth and 6.2...
FDA classifies recall of Medtronic embolization devices as 'most serious'
The U.S. Food and Drug Administration on Tuesday classified the recall of Medtronic's embolization device as "most serious", following reports of the deaths of four patients.
The Big 3: KO, MDT, LHX
Stability is Kenny Polcari's theme when it comes to today's Big 3. He explains why Cola-Cola (KO), Medtronic (MDT) and L3Harris (LHX) are undervalued names with quality.
CGS Transforms Workplace Training with Cicero, a New AI-Driven, Customizable Roleplay Platform
NEW YORK, March 10, 2025 (GLOBE NEWSWIRE) -- CGS Immersive™, the leader in enterprise learning that is modernizing training and development with AI and XR technologies, today introduced Cicero™, a hyp...
SMART Trial two-year data continues to demonstrate superior valve performance for Evolut TAVR™ system in small annulus patients
CRT 2025 Late Breaking Science features largest head-to-head randomized control TAVR trial to primarily enroll women using the two most widely used global TAVR devices GALWAY, Ireland and WASHINGTON ,...
Medtronic announces cash dividend for fourth quarter of fiscal year 2025
GALWAY, Ireland , March 6, 2025 /PRNewswire/ -- The board of directors of Medtronic plc (NYSE: MDT) on Thursday, March 6, 2025, approved the company's cash dividend for the fourth quarter of fiscal ye...
Medtronic explores options to optimize manufacturing operations amid Trump's tariff threats
Medical device maker Medtronic is looking at options to modify its global manufacturing footprint as part of efforts to mitigate any impact of U.S. President Donald Trump's tariff plans, a company exe...
US FDA approves Medtronic's medical device for Parkinson's disease
The U.S. Food and Drug Administration has approved Medtronic's deep brain stimulation system for use in patients with Parkinson's disease, the medical device maker said on Monday.
Medtronic earns U.S. FDA approval for the world's first Adaptive deep brain stimulation system for people with Parkinson's
New closed-loop system self-adjusts DBS therapy to individual brain activity in real time; the largest commercial launch of brain-computer interface technology ever GALWAY, Ireland , Feb. 24, 2025 /...
Medtronic plc (MDT) Q3 2025 Earnings Call Transcript
Medtronic plc (NYSE:MDT) Q3 2025 Earnings Conference Call February 18, 2025 8:00 AM ET Company Participants Ryan Weispfenning - Vice President and Head of Investor Relations Geoff Martha - Chairman a...
Medtronic Q3 Earnings: Cardiovascular And Neuroscience Drive Growth, Surgical Revenue Dips, Reaffirms Annual Forecast
Tuesday, Medtronic Plc MDT reported third-quarter 2025 sales of $8.29 billion, missing the consensus of $8.32 billion.
Medtronic credits heart-surgery-device growth as profit tops analyst estimates
Medtronic said it is “starting to see the results” of its investment in new products.
Medtronic beats quarterly profit estimates on strong heart, diabetes device sales
Medtronic beat Wall Street estimates for quarterly profit on Tuesday, on strong demand for its heart and diabetes devices.
Medtronic reports third quarter fiscal 2025 financial results
Delivering durable revenue growth with strong earnings power; strength in Pulsed Field Ablation, Pacing, Structural Heart, Diabetes, and Neuromodulation GALWAY, Ireland , Feb. 18, 2025 /PRNewswire/ --...
Medtronic: Several Reasons For Optimism Before The Upcoming Earnings Release
Medtronic: Several Reasons For Optimism Before The Upcoming Earnings Release
Retirement Strategy: 2 Dividend Aristocrats At Bargain Prices
Buying battle-tested dividend aristocrats can be a winning strategy for those seeking durable retirement income. What's even better is if they also carry strong balance sheets and are attractively val...
Here are the best performing dividend aristocrats stocks in 2025
Dividend aristocrat stocks have largely done well in the past few years. The closely-followed ProShares S&P 500 Dividend Aristocrats ETF (NOBL) has jumped by over 133% from its lowest level in 2020.
Medtronic to announce financial results for its third quarter of fiscal year 2025
GALWAY, Ireland , Feb. 5, 2025 /PRNewswire/ -- Medtronic plc (NYSE: MDT), a global leader in healthcare technology, today announced that it will report financial results for its third quarter of fisca...
North America Balloon Sinuplasty Systems Market Outlook to 2033, with Profiles of Leading Companies Acclarent, Medtronic and Entellus Medical
Dublin, Feb. 03, 2025 (GLOBE NEWSWIRE) -- The "North America Balloon Sinuplasty Systems Market Outlook to 2033" report has been added to ResearchAndMarkets.com's offering. The comprehensive databook r...
Chart Master: Four stocks on cusp of breakout
Carter Worth, Worth Charting, gives his technical analysis on four stocks on the verge of breaking out.
Medtronic appoints Renault's exec Thierry Piéton as finance chief
Medtronic said on Monday it will appoint Renault's finance chief Thierry Piéton as its Chief Financial Officer, effective March 3.
Medtronic appoints Thierry Piéton as Chief Financial Officer
GALWAY, Ireland , Jan. 21, 2025 /PRNewswire/ -- Medtronic plc (NYSE: MDT), a global leader in healthcare technology, today announced that Thierry Piéton has been appointed Chief Financial Officer for ...
Medtronic plc (MDT) 43rd Annual J.P. Morgan Healthcare Conference (Transcript)
Medtronic plc (NYSE:MDT) 43rd Annual J.P. Morgan Healthcare Conference Call January 13, 2025 5:15 PM ET Company Participants Geoff Martha - Chief Executive Officer Sean Salmon - EVP & President, Card...
Medtronic announces CMS national coverage analysis for Symplicity™ Spyral Renal Denervation System
National coverage analysis is the first-of-its kind for a minimally invasive, interventional treatment for high blood pressure Milestone is supported by large public health need and robust, long-term ...